Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mauer

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
Kidney International|September 11, 2024
Estimating glomerular filtration rate in kidney transplant recipients: considerations for selecting equationsKrishna A Agarwal, Ogechi M Adingwupu, Hocine Tighiouart, et al.
Molecular Genetics and Metabolism|April 17, 2019
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trialUma Ramaswami, Daniel G Bichet, Lorne A Clarke, et al.
Diabetes|January 25, 2019
Genetic Determinants of Glycated Hemoglobin in Type 1 DiabetesAnna Syreeni, Niina Sandholm, Jingjing Cao, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|February 21, 2025
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney DiseaseVikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2023
Performance of GFR Estimating Equations in Young AdultsLesley A Inker, Hocine Tighiouart, Ogechi M Adingwupu, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2015
Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers ConsortiumChi-Yuan Hsu, Shawn Ballard, Daniel Batlle, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
Kidney International|September 11, 2024
Estimating glomerular filtration rate in kidney transplant recipients: considerations for selecting equationsKrishna A Agarwal, Ogechi M Adingwupu, Hocine Tighiouart, et al.
Molecular Genetics and Metabolism|April 17, 2019
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trialUma Ramaswami, Daniel G Bichet, Lorne A Clarke, et al.
Diabetes|January 25, 2019
Genetic Determinants of Glycated Hemoglobin in Type 1 DiabetesAnna Syreeni, Niina Sandholm, Jingjing Cao, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|February 21, 2025
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney DiseaseVikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2023
Performance of GFR Estimating Equations in Young AdultsLesley A Inker, Hocine Tighiouart, Ogechi M Adingwupu, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2015
Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers ConsortiumChi-Yuan Hsu, Shawn Ballard, Daniel Batlle, et al.
Pageof 15